These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Anti-tumor necrosis factor-α agents in noninfectious uveitis. Gueudry J; LeHoang P; Bodaghi B Dev Ophthalmol; 2012; 51():63-78. PubMed ID: 22517205 [TBL] [Abstract][Full Text] [Related]
23. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I. Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS Expert Opin Pharmacother; 2014 Oct; 15(15):2141-54. PubMed ID: 25226529 [TBL] [Abstract][Full Text] [Related]
24. The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis. Lerman MA; Rabinovich CE Paediatr Drugs; 2015 Aug; 17(4):283-301. PubMed ID: 25893479 [TBL] [Abstract][Full Text] [Related]
25. Overview and recent developments in the medical management of paediatric uveitis. Pilly B; Heath G; Tschuor P; Lightman S; Gale RP Expert Opin Pharmacother; 2013 Sep; 14(13):1787-95. PubMed ID: 23826652 [TBL] [Abstract][Full Text] [Related]
26. Biologics in the treatment of uveitis. Imrie FR; Dick AD Curr Opin Ophthalmol; 2007 Nov; 18(6):481-6. PubMed ID: 18163000 [TBL] [Abstract][Full Text] [Related]
31. Use of tumor necrosis factor inhibitors in uveitis. Rabinovich CE Curr Opin Rheumatol; 2007 Sep; 19(5):482-6. PubMed ID: 17762615 [TBL] [Abstract][Full Text] [Related]
32. Biologic Therapies: Anti-Tumor Necrosis Factor-α, Anti-Interleukins, Rituximab and Others. Bhatt N; Tucker W; Sen HN; Nussenblatt RB Dev Ophthalmol; 2016; 55():252-64. PubMed ID: 26501216 [TBL] [Abstract][Full Text] [Related]
33. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Nguyen QD; Merrill PT; Jaffe GJ; Dick AD; Kurup SK; Sheppard J; Schlaen A; Pavesio C; Cimino L; Van Calster J; Camez AA; Kwatra NV; Song AP; Kron M; Tari S; Brézin AP Lancet; 2016 Sep; 388(10050):1183-92. PubMed ID: 27542302 [TBL] [Abstract][Full Text] [Related]
34. IL-6 blockade in the management of non-infectious uveitis. Lopalco G; Fabiani C; Sota J; Lucherini OM; Tosi GM; Frediani B; Iannone F; Galeazzi M; Franceschini R; Rigante D; Cantarini L Clin Rheumatol; 2017 Jul; 36(7):1459-1469. PubMed ID: 28528519 [TBL] [Abstract][Full Text] [Related]
35. [Clinical features and therapy of uveitis in childhood]. Kiss J; Gaál V; Nyul Z; Mosdósi B Orv Hetil; 2019 Aug; 160(34):1335-1339. PubMed ID: 31423830 [TBL] [Abstract][Full Text] [Related]
36. Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis. Thomas J; Kuthyar S; Shantha JG; Angeles-Han ST; Yeh S Ann Eye Sci; 2021 Jun; 6():. PubMed ID: 34131629 [TBL] [Abstract][Full Text] [Related]
38. Treatment of chronic non-infectious uveitis and scleritis. Rossi DC; Ribi C; Guex-Crosier Y Swiss Med Wkly; 2019 Feb; 149():w20025. PubMed ID: 30852832 [TBL] [Abstract][Full Text] [Related]
39. Pediatric uveitis: new and future treatments. Mehta PJ; Alexander JL; Sen HN Curr Opin Ophthalmol; 2013 Sep; 24(5):453-62. PubMed ID: 23872814 [TBL] [Abstract][Full Text] [Related]
40. Update on noninfectious uveitis in children and its treatment. Maccora I; Sen ES; Ramanan AV Curr Opin Rheumatol; 2020 Sep; 32(5):395-402. PubMed ID: 32675714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]